Director, Medical Science Liaison, North Central

Das ist der Job

Position Summary We are seeking a Director, MSL who will report to the Senior Director, Western US Field Medical.

Darum lohnt es sich

MSL’s combine a strong business acumen, disease state knowledge, clinical knowledge/experience, market awareness, and serve as a conduit for Celcuity’s scientific data to external customers while providing external market and clinical insights internally to cross-functional teams.

Maintain cross-functional field partnerships allowing for appropriate collaboration with field commercial teams (sales, market access, etc.), and Clinical Development associates.

Assist the Clinical Development Team in the identification and education of potential clinical trial sites, assist, upon request, in troubleshooting issues during clinical trial conduct.

Qualifications MD, PharmD, or PhD in Life Sciences, D.Sc., D.N.P, or D.O. degree Solid tumor oncology experience Excellent presentation and communication skills Conveying complex scientific concepts and information appropriately tailored to the audience (internal staff, physicians, nurses, patient advocacy groups, formulary committees, etc.) 3+ years of related pharmaceutical Medical Science Liaison experience Breast Cancer experience Knowledge of clinical research design and GCP in the oncology area Experiences at small / start-up biopharmaceutical company Strong business acumen Experience with payor groups, market access teams, formulary committees, and treatment guidelines Experience managing territory resources and budgets.

Compensation & Benefits For this role, the anticipated base pay range is $230,000-$256,000 DOE .

Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays. #J-18808-Ljbffr Location: North Central (Minnesota, Iowa, Nebraska, South Dakota, North Dakota, Kansas, Missouri) This region does not include Illinois, but the prospective new hire can reside in the Chicagoland area.

The Director, MSL will be responsible for scientific exchange with Health Care Providers (HCPs) and key decision makers (managed care, payers, formulary committees, etc.) on Celcuity’s products, relevant disease states, and in support of clinical trials. Travel within the territory and the US for medical conferences will be expected.

Responsibilities Identify and cultivate professional relationships Key Opinion Leaders (KOLs) in designated tumor types. Maintain and develop synergistic relationships with KOLs to expand research, advisory, and educational partnership opportunities.

Develop scientific expertise on all Celcuity’s products, related disease states, and the clinical practice for a given therapeutic area. Communicate scientific content, written and verbal, related to Celcuity’s products and related disease states.

Be knowledgeable of and follow all applicable laws, SOPs and guidance documents ensuring compliance Provide scientific training to internal colleagues. Participate in the Medical, Legal, and Regulatory review process, as needed, in the role of scientific expert.

Identify, categorize, and communicate key clinical insights related to assigned disease state and products. Other duties as assigned.

Demonstrated self-starter Experience launching products About Us Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications.

The company was founded to develop a better way to treat the cellular drivers of tumor growth. Our lead therapeutic candidate, gedatolisib, is an intravenously administered, potential first-in-class PI3K/AKT/mTOR (PAM) pathway inhibitor.

Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings.

A Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is on-going. Equal Opportunity Employer Celcuity is an Equal-Opportunity Employer.

Celcuity is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are competitive. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience.

The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package.